Home › Premarket Biotech Digest: Harvoni's Label Expansion, AstraZeneca's...
 

Keywords :   


Premarket Biotech Digest: Harvoni's Label Expansion, AstraZeneca's...

2015-11-16 15:58:38| Biotech - Topix.net

Click this link to find out how much you can save.) Last week, Gilead Sciences announced that its Harvoni has been approved by the FDA in new indications. The FDA approved the blockbuster drug for expanded use in patients with genotype 4, 5 and 6 chronic HCV infections and in patients co-infected with HIV.

Tags: label expansion digest biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05We Recycle Solar Expands Partnership with Renewables.org
20.05Washington State Authorizes Drone for Methane Emissions
20.05The Heart, Science & Business of Sustainability: A Fireside Chat with Tara Hemmer
20.05Commissioners Celebrate the Opening of New Waste Transfer Station in Redmond, Ore.
20.05Newhaven Food Waste Facility Plans Paused Following Residents Concerns
20.05Business Report May 2024Highlights from WasteExpo 2024
More »